3325 related articles for article (PubMed ID: 7539783)
1. Inhibition of tumor-induced angiogenesis by a synthetic lipid A analogue with low endotoxicity, DT-5461.
Sato K; Yoo YC; Mochizuki M; Saiki I; Takahashi TA; Azuma I
Jpn J Cancer Res; 1995 Apr; 86(4):374-82. PubMed ID: 7539783
[TBL] [Abstract][Full Text] [Related]
2. DT-5461, a new synthetic lipid A analogue, inhibits lung and liver metastasis of tumor in mice.
Sato K; Saiki I; Yoo YC; Igarashi Y; Kiso M; Hasegawa A; Azuma I
Jpn J Cancer Res; 1992 Oct; 83(10):1081-7. PubMed ID: 1452460
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of tumor-induced angiogenesis by the administration of recombinant interferon-gamma followed by a synthetic lipid-A subunit analogue (GLA-60).
Saiki I; Sato K; Yoo YC; Murata J; Yoneda J; Kiso M; Hasegawa A; Azuma I
Int J Cancer; 1992 Jun; 51(4):641-5. PubMed ID: 1376302
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral production of tumor necrosis factor augmented by endogenous interferons results in potent antitumor effects of DT-5461, a synthetic lipid A analog.
Kumazawa E; Akimoto T; Kita Y; Jimbo T; Joto N; Tohgo A
J Immunother Emphasis Tumor Immunol; 1995 Apr; 17(3):141-50. PubMed ID: 7542128
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of Korean mistletoe (Viscum album coloratum) extract on tumour angiogenesis and metastasis of haematogenous and non-haematogenous tumour cells in mice.
Yoon TJ; Yoo YC; Choi OB; Do MS; Kang TB; Lee SW; Azuma I; Kim JB
Cancer Lett; 1995 Oct; 97(1):83-91. PubMed ID: 7585483
[TBL] [Abstract][Full Text] [Related]
6. Antimetastatic effect of endogenous tumor necrosis factor induced by the treatment of recombinant interferon gamma followed by an analogue (GLA-60) to synthetic lipid A subunit.
Saiki I; Maeda H; Murata J; Yamamoto N; Kiso M; Hasegawa A; Azuma I
Cancer Immunol Immunother; 1989; 30(3):151-7. PubMed ID: 2513113
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng.
Mochizuki M; Yoo YC; Matsuzawa K; Sato K; Saiki I; Tono-oka S; Samukawa K; Azuma I
Biol Pharm Bull; 1995 Sep; 18(9):1197-202. PubMed ID: 8845804
[TBL] [Abstract][Full Text] [Related]
8. Effect of U-995, a potent shark cartilage-derived angiogenesis inhibitor, on anti-angiogenesis and anti-tumor activities.
Sheu JR; Fu CC; Tsai ML; Chung WJ
Anticancer Res; 1998; 18(6A):4435-41. PubMed ID: 9891506
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2.
Sato K; Mochizuki M; Saiki I; Yoo YC; Samukawa K; Azuma I
Biol Pharm Bull; 1994 May; 17(5):635-9. PubMed ID: 7522731
[TBL] [Abstract][Full Text] [Related]
10. Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice.
Yoo YC; Watanabe S; Watanabe R; Hata K; Shimazaki K; Azuma I
Jpn J Cancer Res; 1997 Feb; 88(2):184-90. PubMed ID: 9119747
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of DT-5461a, a synthetic low-toxicity lipid A analog, involves endogenous tumor necrosis factor induction subsequent to macrophage activation.
Akimoto T; Kumazawa E; Jimbo T; Joto N; Tohgo A
Int J Immunopharmacol; 1994 Nov; 16(11):887-93. PubMed ID: 7868293
[TBL] [Abstract][Full Text] [Related]
12. A novel synthetic lipid A analog with low endotoxicity, DT-5461, prevents lethal endotoxemia.
Sato K; Yoo YC; Fukushima A; Saiki I; Takahashi TA; Fujihara M; Tono-Oka S; Azuma I
Infect Immun; 1995 Aug; 63(8):2859-66. PubMed ID: 7622206
[TBL] [Abstract][Full Text] [Related]
13. Bovine lactoferrin and Lactoferricin inhibit tumor metastasis in mice.
Yoo YC; Watanabe S; Watanabe R; Hata K; Shimazaki K; Azuma I
Adv Exp Med Biol; 1998; 443():285-91. PubMed ID: 9781371
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tumor-induced angiogenesis by sulfated chitin derivatives.
Murata J; Saiki I; Makabe T; Tsuta Y; Tokura S; Azuma I
Cancer Res; 1991 Jan; 51(1):22-6. PubMed ID: 1703032
[TBL] [Abstract][Full Text] [Related]
15. Involvement of tumor necrosis factor alpha and very late activation antigen 4/vascular cell adhesion molecule 1 interaction in surgical-stress-enhanced experimental metastasis.
Higashiyama A; Watanabe H; Okumura K; Yagita H
Cancer Immunol Immunother; 1996 May; 42(4):231-6. PubMed ID: 8665570
[TBL] [Abstract][Full Text] [Related]
16. Endotoxin antagonism by a synthetic lipid A analogue, DT-5461, with low endotoxicity in human peripheral blood monocytes.
Sato K; Fujihara M; Takahashi TA; Choon Yoo Y; Hata K; Tono-Oka S; Suzuki T; Sekiguchi S; Azuma I
Biochem Biophys Res Commun; 1995 Nov; 216(1):367-74. PubMed ID: 7488114
[TBL] [Abstract][Full Text] [Related]
17. Systemic administration of a synthetic lipid A derivative, DT-5461a, reduces tumor blood flow through endogenous TNF production in hepatic cancer model of VX2 carcinoma in rabbits.
Jimbo T; Akimoto T; Tohgo A
Anticancer Res; 1996; 16(1):359-64. PubMed ID: 8615636
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effect of DT-5461, a lipid A derivative, against human tumor xenografts is mediated by intratumoral production of tumor necrosis factor and affected by host immunosuppressive factors in nude mice.
Kumazawa E; Jimbo T; Akimoto T; Joto N; Tohgo A
Cancer Invest; 1997; 15(6):522-30. PubMed ID: 9412657
[TBL] [Abstract][Full Text] [Related]
19. Effect of the synthetic lipid A-related compound, DT-5461, on resistance to Sendai virus infection in mice.
Yoshida R; Sato K; Yoo YC; Yoshimatsu K; Tamura M; Ishihara C; Arikawa J; Azuma I
Immunopharmacology; 1994; 28(2):153-61. PubMed ID: 8002289
[TBL] [Abstract][Full Text] [Related]
20. New nortriterpenoid isolated from anti-rheumatoid arthritic plant, Tripterygium wilfordii, modulates tumor growth and neovascularization.
Ushiro S; Ono M; Nakayama J; Fujiwara T; Komatsu Y; Sugimachi K; Kuwano M
Int J Cancer; 1997 Aug; 72(4):657-63. PubMed ID: 9259407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
